Poniard Pharmaceuticals (PARD) Inactive 10-Q2002 Q3 Quarterly report

Filed: 14 Nov 02, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Good

New words: accrual, accrued, audit, Avenue, Becky, Bottino, Certification, certify, certifying, committee, conserve, corrective, covered, decommissioning, Elliott, fact, fraud, kile, knowledge, length, Les, letter, light, MD, melinda, noncompliance, originally, PhD, reassessing, regain, rent, role, royalty, Sabo, senior, situation, space, speak, summarize, thereof, undertaken, untrue, unused, Vice

Removed: apply, area, check, Click, conducted, establish, fashion, forward, Identification, mark, navigate, par, preceding, rapidly, shorter, telephone, workforce

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

PARD similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 99.2

Certification of Periodic Report

I, Melinda G. Kile, Vice President of Finance of NeoRx Corporation (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

1. the Quarterly Report on Form 10-Q for the Company for the quarterly period ended September 30, 2002 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (12 U.S.C. 78m or 78o(d)); and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 14, 2002	By:	/s/ MELINDA G. KILE
	Melinda G. Kile

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.